RxDoctor Payments Data

John Fenlin

Orthopaedic Surgery · Philadelphia, PANPI 1700830361

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $5,861,287 of the $5,861,287 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Stryker. Reporting peaked in 2022 at $1,154,803 and has fallen 50.5% since, to $571,310 in 2025. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,861,287in general payments, 2019–2025

Across 56 payments — averaging $104,666 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$5.9M

What the payments were for

  • Royalty or licence$5,861,287100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker(2 entities)56$5,861,287

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,861,287 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Other orthopaedic surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →